Live feed16:13:37·48dINSIDERFilingEVP Chief R&D Garg Pushkal sold $1,524,796 worth of shares (4,713 units at $323.53), decreasing direct ownership by 20% to 18,693 units (SEC Form 4)ALNY· Alnylam Pharmaceuticals Inc.Health CareOriginal source